Brief: Biostage posts Q2 loss per share $0.10
14/08/2017 12:00
Aug 14 (Reuters) - Biostage Inc BSTG.O
* Biostage reports 2017 second quarter financial results:
* Q2 loss per share $0.10
Source text for Eikon: ID:nPn6tyjnQa
Further company coverage: BSTG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer